SAN JOSE, Calif., April 15, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that its Board of Directors has approved a reverse stock split of its common stock at a ratio of 1-for-25. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Ticker: BPMX. HEAD-0.092298030853271. BioPharmX Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of  Stock Performance NYSEMKT:BPMX Stock Symbol BPMX Stock Exchange NYSEAMERICAN - NYSE American IPO Date Jul 1, 2015 Valuation at IPO $68M   BioPharmX shares stayed stable 0.00% to $0.36 today. On Dec/11 BPMX rocketed an amazing 12.82%. On December 10th BPMX plummed a hair-raising   BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SAN JOSE, Calif., April 15, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that its Board of Directors has approved a reverse stock split of its common stock at a ratio of 1-for-25.

Based on our forecasts, a long-term increase is expected, the "BPMX" stock price prognosis for 2024-10-09 is 1.435 USD. With a 5-year investment, the revenue is expected to be around +324.59%. Your current $100 investment may be up to $424.59 in 2024.

Stock analysis for BioPharmX Corp (BPMX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Biopharmx Corp files for offering of up to $40.3 million of shares of common stock - SEC filing Source text: [http://bit.ly/2l2DwCb] Further company coverage:. Get today's BioPharmX Corp stock price and latest BPMX news as well as BioPharmX real-time stock quotes, technical analysis, full financials and more. Company Name: BioPharmX Corp., Stock Symbol: BPMX, Industry: Medical - Drugs, Total Posts: 2994, Last Post: 3/10/2020 2:23:01 PM. See BioPharmX price target based on 1 analysts offering 12 month price targets for BioPharmX in the last 3 months. Follow BPMX to track price target and stock 

Trading Signals for Biopharmx Corp with Buy, Sell, Hold recommendations, technical analysis, and trading strategy.

BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Find the latest BioPharmX Corporation (BPMX) stock quote, history, news and other vital information to help you with your stock trading and investing.

BioPharmX Corporation (BPMX) News. BPMX Home · BPMX News Updated Mar 12 2:24pm. Add BPMX to Watchlist See all "A" rated Strong Buy stocks  These institutions hold a total of 2,456,872 shares. Largest shareholders include Empery Asset Management, LP, Frenkel Leonid, Barclays Plc, Vanguard Group  18 Feb 2020 On Friday, shares of BioPharmX Corporation (NYSE:BPMX) marked $0.40 per share versus a previous $0.37… 17 May 2019 Biopharmx Corp (BPMX) stock is lower by -78.45% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. 21 Jan 2020 BioPharmX Corporation [BPMX] has 15.38M shares outstanding, amounting to a total market cap of $7.23M. Its stock price has been found in the 

Get today's BioPharmX Corp stock price and latest BPMX news as well as BioPharmX real-time stock quotes, technical analysis, full financials and more.

BioPharmX shares stayed stable 0.00% to $0.36 today. On Dec/11 BPMX rocketed an amazing 12.82%. On December 10th BPMX plummed a hair-raising   BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. SAN JOSE, Calif., April 15, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that its Board of Directors has approved a reverse stock split of its common stock at a ratio of 1-for-25. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

BPMX | Complete BioPharmX Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. BioPharmX Corporation Common Stock (BPMX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Our stock is listed on the NYSE American under the ticker symbol BPMX. View our latest investor presentation. About · Company · Management Team · Board of   Researching Biopharmx (NYSEAMERICAN:BPMX) stock? View BPMX's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.